Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2026-03-31 @ 12:53 PM
Study NCT ID:
NCT02100358
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2014-03-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Functional MRC With Eovist for Acute Cholecystitis
Sponsor:
University of California, Davis
Organization:
Study Overview
Official Title:
Accuracy of Functional MRC With Gadoxetate Disodium in the Diagnosis of Acute Cholecystitis: Comparison With Hepatobiliary Scintigraphy
Status:
COMPLETED
Status Verified Date:
2017-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MRC
Brief Summary:
Functional magnetic resonance cholangiography (fMRC) with gadoxetate disodium (Eovist) is an accurate method of diagnosing acute cholecystitis.
Detailed Description:
Primary Objective:
To determine the accuracy of fMRC in evaluating patients with suspected cholecystitis.
Secondary Objective:
To compare the results of fMRC with conventional hepatobiliary scintigraphy.
To determine the accuracy of fMRC in evaluating patients with suspected cholecystitis.
Secondary Objective:
To compare the results of fMRC with conventional hepatobiliary scintigraphy.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: